119-hr2592

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2592 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 2592

To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
 purposes of the medical certification of airmen, and for other 
 purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 April 2, 2025

Mr. Casten (for himself and Mr. Stauber) introduced the following bill; 
 which was referred to the Committee on Transportation and 
 Infrastructure

_______________________________________________________________________

 A BILL

To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
 purposes of the medical certification of airmen, and for other 
 purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Aviation Medication Transparency Act 
of 2025''.

SEC. 2. LIST OF APPROVED MEDICATIONS.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Administrator of the Federal Aviation Administration 
shall publish and maintain on a publicly available website of the 
Administration the list of medications and treatments that may be 
safely prescribed to an airman to treat certain medical conditions that 
the Administrator has compiled for purposes of the issuance of a 
medical certification to an airman.

    (b) Requirements.--The list required under subsection

    (a) shall--

    (1) be drafted in consultation with--
        (A) the Aeromedical Innovation and Modernization 
 Working Group;
        (B) the certified exclusive bargaining 
 representatives of air traffic controllers of the 
 Administration certified under 

section 7111 of title 5, 
 United States Code;
            (C) the principal organization representing the 
 largest certified collective bargaining representative 
 of airline pilots; and
            (D) any other stakeholder determined relevant by 
 the task group, including any stakeholders described in 
 

section 411
            (d) (3)
        (B) of the FAA Reauthorization Act of 
 2024;

    (2) be comprehensive;

    (3) be drafted in a user-friendly and accessible manner and 
 provided to airmen at the time when such airmen first seek a 
 license and medical certification;

    (4) indicate what, if any, period of time, on average, an 
 airman must have limited or no duties to stabilize on an 
 approved medication;

    (5) include the list of medications that the Administrator 
 has designated as ``Do Not Issue'';

    (6) include a mechanism for doctors or medical providers to 
 contact the Federal Aviation Administration regarding questions 
 related to such list;

    (7) include any additional information that the 
 Administrator determines is appropriate to provide with respect 
 to what conditions a certain medication may or may not be used 
 to treat and any information to explain why a medication is 
 allowed or prohibited by the Federal Aviation Administration; 
 and

    (8) include any other information or clarification that the 
 Administrator determines appropriate.
            (c) Annual Update.--Not later than 1 year after the date of 
publication of the list required under subsection

    (a) , and annually 
thereafter, the Administrator shall update such list, as appropriate.
 <all>